Case Report

Ependymoma with L-2-hydroxyglutaric aciduria: case report of two siblings

Volume: 58 Number: 4 December 30, 2019
  • Semra Bahar *
  • Tanyel Zübarioğlu
  • Mehmet Şerif Cansever
  • Cengiz Yalçınkaya
EN TR

Ependymoma with L-2-hydroxyglutaric aciduria: case report of two siblings

Abstract

L-2-hydroxyglutaric aciduria (L2HGA) is a slowly progressive, autosomal recessive neurodegenerative disorder. Characteristic clinical features of the disease include developmental delay, behavioral disorders, febrile and afebrile seizures. Frequent abnormal examination findings can be listed as macrocephaly, mental retardation, cerebellar ataxia, pyramidal and extrapyramidal signs. Brain magnetic resonance imaging (MRI) features are characterized by subcortical white matter, basal ganglia and cerebellar dentate nuclei alterations. Definite diagnosis can be made by determination of elevated 2-hydroxyglutaric acid accumulation in plasma, urine and cerebrospinal fluid and by molecular diagnosis of L2HGDH gene accompanied by clinical and radiological findings. Malignant brain tumors have been reported in the course of L2HGA. Here, a patient that was operated because of brain tumor in adolescence and in whom the L2HGA diagnosis was made by abnormal brain MRI features is reported. Following the diagnosis, her sister was also diagnosed as L2HGA due to family screening. In the light of these cases, it is emphasized that metabolic diseases should be included in differential diagnosis of brain tumors in early life especially in existence of neurodevelopmental delay, mental retardation and pathological examination findings. Specific radiological features of neurometabolic disorders and importance of family screening in metabolic diseases are also highlighted.

Keywords

References

  1. Van Schaftingen E, Rzem R, Veiga-da-Cunha M. L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair. J Inherit Metab Dis 2009; 32 (2): 135-42.
  2. Hoffmann GF, Kölker S. Cerebral Organic Acid Disorders and Other Disorders of Lysine Catabolism. In: Saudubray JM, Baumgartner MR, Walter. J (eds). Inborn Metabolic Diseases Diagnosis and Treatment. 6th Edn. Berlin,Heidelberg: Springer; 2016: 333-48.
  3. Steenweg ME, Salomons GS, Yapici Z, et al. L-2-Hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients. Radiology 2009;251(3):856-65.
  4. Yilmaz K. Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 2009;13(1):57-60.
  5. Samuraki M, Komai K, Hasegawa Y, et al. A successfully treated adult patient with L-2-hydroxyglutaric aciduria. Neurology 2008; 70 (13): 1051-2.
  6. Faiyaz-Ul-Haque M, Al-Sayed MD, Faqeih E, et al. Clinical, neuroimaging, and genetic features of L-2- hydroxyglutaric aciduria in Arab kindreds. Ann Saudi Med. 2014;34(2):107-14.
  7. Steenweg ME, Jakobs C, Errami A, et al. An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study. Hum Mutat. 2010;31(4):380-90.
  8. Fourati H, Ellouze E, Ahmadi M, et al. MRI features in 17 patients with l2 hydroxyglutaric aciduria. Eur J Radiol Open 2016; 3: 245-50.

Details

Primary Language

Turkish

Subjects

Health Care Administration

Journal Section

Case Report

Authors

Tanyel Zübarioğlu
0000-0002-7159-4008
Türkiye

Mehmet Şerif Cansever
0000-0003-3315-5124
Türkiye

Cengiz Yalçınkaya
0000-0002-3443-8524
Türkiye

Publication Date

December 30, 2019

Submission Date

October 9, 2018

Acceptance Date

November 21, 2018

Published in Issue

Year 1970 Volume: 58 Number: 4

Vancouver
1.Semra Bahar, Tanyel Zübarioğlu, Mehmet Şerif Cansever, Cengiz Yalçınkaya. Ependimom ve L-2-hidroksiglutarik asidüri: İki kardeş olgu sunumu. EJM. 2019 Dec. 1;58(4):418-21. doi:10.19161/etd.665861

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.